Sent on behalf of Peter Myllymaa, Executive Vice President, Corporate Services and Operations

---

I am pleased to announce that Agha Hasan has accepted the position of Director of Cyclotron Operations. Agha is currently the Manager of Quality Assurance & Compliance with the Cyclotron, a position he has held since 2019. In order to meet stringent Health Canada requirements, Agha will continue in his current role until we successfully hire a new Manager of Quality Assurance & Compliance. In the interim, Amarjit Chahal will continue to act as the Interim Director of Cyclotron Operations.

As the Director of Cyclotron Operations, Agha will be responsible for overseeing the operations of the Cyclotron Facility and its role for production of radiopharmaceuticals for clinical use, research and commercial opportunities. Agha is a graduate of the Biotechnology PhD program at Lakehead University, specializing in Chemical Engineering. Agha is a quality assurance professional with a breadth of experience in the pharma & radio pharma industry. As the current Manager of Quality Assurance & Compliance with the Cyclotron, he has gained knowledge of various aspects of the facility, including experience with commissioning and Canadian Nuclear Safety Commission and Health Canada licensing, to oversight and implementation of a quality control program for 18FDG intended for clinical use. Agha will continue to work out of the Cyclotron Facility and can be reached at 684-7008 or hasana@tbh.net.

Please join me in congratulating Agha in his new role.

I would also like to extend a sincere thank you to Amarjit Chahal for his continued support with interim coverage and leadership to the Cyclotron Facility.